We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 314

Doctrine of bona fide purchaser for value without notice applies to patent rights

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 6 2012

This case involves a dispute over who owned certain patent rights

Tesla’s patent pledge: is it enough?

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 23 2014

Free use of patented technology? Caveat emptor. In a June 12, 2014 blog post titled, "All Our Patent Are Belong To You", Elon Musk, co-founder and

Reply affidavits allowed when new documents introduced in responding evidence

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 9 2014

In this case, there is a partial reversal of evidence. Apotex brought a motion for leave to file reply evidence. Allergan did not oppose parts of the

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 15 2013

Obviousness and lack of patentable subject matter were cited by the Examiner as the basis for rejecting the patent application before the Patent

Intellectual property weekly abstract bulletin - week of 7th October 2013

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 7 2013

The Federal Court has dismissed an application to prohibit the Minister of Health from issuing a Notice of Compliance to the Respondent Cobalt in

Experts permitted to attend testing at plaintiff's facility

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 2 2014

This Order was issued in 2012, but just made public now. The defendant brought a motion seeking to permit its experts to attend testing, for samples

Patent held invalid for not meeting promise of improved therapeutic profile

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 10 2014

Apotex was successful in the previous NOC Proceeding. It came to market with an esomeprazole product. AstraZeneca sued for patent infringement and

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 22 2013

A Member of the Trade-marks Opposition Board (Member) refused the registration of MACDIMSUM for a variety of food and drink items (the Trade-mark

Claim to disgorgement of profits denied by Ontario Court of Appeal

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • September 18 2013

Apotex appealed in the Ontario Court of Appeal from a partial summary judgment that dismissed its unjust enrichment claim for the disgorgement of the

Wenzel Downhole Tools et al. v. National-Oilwell Canada et al.

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 5 2010

This is a patent infringement action